Money

Dan Vasella, the chief executive of Swiss firm Novartis, which has been struggling for the last five years to secure the patent rights in India on Glivec, its therapy for a rare form of blood cancer called chronic myeloid leukemia, has spoken again on the alleged gaps in the Indian patent system.

Popular » Viewed Emailed Money » Zee Turner to take 33 channels off Hathway Cognizant sees offshoring budgets up Boeing's new 747 takes flight near Seattle Sensex closes above 16,000 on global cues; IT, PSUs rally GMR Infra wins road contract from National Highways Authority of India Other sections » Sena targets Arindham Chaudhari over 'separate Mumbai' remark 200 Shiv Sena activists held for anti-SRK stir SRK protests: Maha CM threatens to withdraw Uddhav's security Bal Thackeray again attacks Rahul Gandhi Pak likely to take tough line on talks Money » TechMahindra accounting continues to fox India still not lucrative for innovator drugs Tyre shortage hurting CV production For a long-term play, opt for Nabard bonds Barclays CEO: Reform should allow smoother failures Other sections » Now, iPhone application that can cure acne Official's visit has nothing to do with BT Brinjal: US Embassy Auto fare hike makes Bus Rapid Transit System richer in Gujarat Solar energy can be used to combat climate change: Experts Assam professor dies of 'medical negligence' in Bangalore Gallery » Going platinum The preview of Sakti Burman's show of serigraphs was hosted by art collector Lavesh Jagasia on Monday at the Pundole Art Gallery Girls wanna have fun Wine connoisseur Shamita Singha hosted a wine appreciation dinner for some of her friends as she took them through a number of wines paired with a four-course meal. Newsletter » Get daily news in your inbox and read it at your convenience. About DNA | Contact Us | Advertise with Us | Subscription | Reprint Rights ©2010 Diligent Media Corporation Ltd. D 910